- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Triple-negative Metastatic Breast Cancer in Australia
Total 676 results
-
Medical University InnsbruckCompletedAlopecia | Breast Cancer FemaleAustria
-
Hoffmann-La RocheEuropean Organisation for Research and Treatment of Cancer - EORTC; NCIC Clinical... and other collaboratorsCompletedBreast CancerFrance, Spain, Switzerland, Greece, Italy, Korea, Republic of, Australia, Canada, Poland, Belgium, United Kingdom, Netherlands, Germany, Chile, Ireland, Portugal, South Africa, Sweden, China, Austria, Hungary, Brazil, Colombia, Thailand, Denma... and more
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Spain, Korea, Republic of, Taiwan, Australia, Canada
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedBreast CancerFrance, Spain, Switzerland, Australia, Belgium, Austria, Peru, Germany, Italy, Japan, New Zealand, Sweden, Denmark, India, United States, Chile, Russian Federation, United Kingdom, Hungary, South Africa
-
Swiss Group for Clinical Cancer ResearchThe Belgian Society of Medical OncologyTerminatedBreast CancerSwitzerland, Belgium, Austria
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedBreast CancerSpain, Poland, Italy, Austria, Russian Federation, Slovakia, Hungary, Germany, Czech Republic, Estonia, Latvia
-
European Organisation for Research and Treatment...CompletedBreast CancerFrance, Spain, Netherlands, United Kingdom, Italy, Israel, Switzerland, Greece, Austria
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
Hoffmann-La RocheCompletedBreast CancerFrance, Spain, Canada, Australia, Russian Federation, Austria, United Kingdom, Italy, Turkey, Bosnia and Herzegovina, Argentina, Romania, Brazil, Mexico, Uruguay, Czech Republic
-
BiogenCompletedBreast CancerUnited States, Russian Federation, Australia, Belgium
-
AstraZenecaCompletedBreast CancerCroatia, Sweden, Czech Republic, France, Italy, Peru, Turkey, United Kingdom, Romania, Finland, Australia, Austria, Belgium, Switzerland, Greece, Colombia, Chile, Venezuela
-
Puma Biotechnology, Inc.CompletedBreast CancerUnited States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
-
ETOP IBCSG Partners FoundationPfizerRecruitingBreast Cancer RecurrentSwitzerland, Italy, France, Spain, Hungary, Austria
-
Hutchison Medipharma LimitedActive, not recruitingMetastatic Colorectal Cancer | Metastatic Colon CancerUnited States, Spain, Japan, Australia, Austria, Belgium, Czechia, Estonia, France, Germany, Hungary, Italy, Poland, United Kingdom
-
AstraZenecaCompletedBreast CancerGermany, Norway, Austria
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid TumoursAustralia
-
Ontario Clinical Oncology Group (OCOG)Canadian Institutes of Health Research (CIHR); Canadian Breast Cancer Research...CompletedBreast CancerCanada, Australia, New Zealand
-
Merrimack PharmaceuticalsTerminatedBreast Cancer | HER2 Positive Breast CancerSpain, United States, Italy, France, Canada, Belgium, Austria, Germany, Czech Republic
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Hoffmann-La RocheRecruitingEarly Breast CancerUnited States, France, Korea, Republic of, Spain, China, Italy, Taiwan, Sweden, Czechia, Hungary, Japan, Greece, Ukraine, Australia, Brazil, Canada, Mexico, Belgium, Argentina, Chile, Serbia, Colombia, Ireland, Hong Kong, Austria, South Africa and more
-
Seagen Inc.CompletedHER2 Positive Breast CancerUnited States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Medical University of ViennaUnknownColorectal Cancer | Peritoneal MetastasisAustria
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, France, Taiwan, Hungary, Germany, Singapore, Austria, Netherlands, Australia, Russian Federation, Spain, Canada, Israel, Japan, Korea, Republic of, Italy, United States, United Kingdom, Brazil, Hong Kong, Czech Republic, South...
-
AmgenAustrian Breast and Colorectal Cancer Study GroupCompletedBreast CancerAustria, Sweden
-
Trans Tasman Radiation Oncology GroupAustralasian Lung Cancer Trials GroupCompletedCancer | Metastases to the LungAustralia
-
University Hospitals of Derby and Burton NHS Foundation...University of Nottingham; Breast Cancer Trials, Australia and New Zealand; Sussex... and other collaboratorsActive, not recruitingBreast CancerUnited Kingdom, New Zealand, Australia
-
Hoffmann-La RocheCompletedBreast CancerFrance, Germany, Spain, Canada, Sweden, South Africa, Portugal, Taiwan, Belgium, Austria, Korea, Republic of, United Kingdom, Australia, Netherlands, Thailand, Mexico, Poland, China, Italy, Switzerland, Lithuania, Brazil, Romania, Panama
-
K-Group, Beta, Inc., a wholly owned subsidiary...PfizerRecruitingMetastatic Colorectal CancerSpain, Australia, United States, Italy, Germany, Poland, Hungary
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
ETOP IBCSG Partners FoundationCompletedBreast Cancer | OsteoporosisFrance, Italy, Switzerland, Australia, Peru, Spain, New Zealand, South Africa
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, France, Sweden, Canada, Finland, Italy, Greece, Mexico, Costa Rica, Poland, Brazil, Guatemala, Panama
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerUnited States, France, Canada, Brazil, Poland, Germany, Portugal, Spain, Sweden, Slovakia, Czech Republic, Uruguay, Argentina, Egypt, Hungary, Israel, South Africa, Austria, Greece, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast CancerUnited States, Belgium, Canada, France, Spain, Turkey, Japan, Egypt, Germany, Austria, Poland, Sweden, United Kingdom, Thailand, Hungary, Australia, Italy, Netherlands, Brazil, Hong Kong, Czech Republic, Korea, Republic of, New Zealand and more
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingBreast CancerUnited States, Spain, Korea, Republic of, China, France, Germany, Japan, Belgium, Italy, Australia, United Kingdom, Canada, Singapore
-
SanofiCancer International Research Group (CIRG)CompletedBreast CancerFrance, Hong Kong, Korea, Republic of, Russian Federation, Spain, United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, China, Colombia, Croatia, Cyprus, Czech Republic, Egypt, Estonia, ... and more
-
Novartis PharmaceuticalsCompletedBreast CancerCanada, Italy, Czechia, United States, Belgium, Austria, Germany, Spain, Japan, Lebanon, Australia, Bulgaria, Israel, Netherlands, Colombia, Hong Kong, Brazil
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
AstraZenecaQuintiles; University of Tubingen - GermanyCompletedBreast CancerUnited States, Bulgaria, Italy, Korea, Republic of, Russian Federation, Spain, Turkey, Canada, Poland, Australia, Hungary, Taiwan, Japan, Germany, United Kingdom
-
Eli Lilly and CompanyCompletedMelanoma | Breast Cancer | Non-small Cell Lung Cancer | Brain MetastasesSpain, United States, Australia, Italy, France, Belgium, Canada, Austria, Israel
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); Breast International GroupActive, not recruitingBreast CancerUnited States, Australia, Switzerland, Italy, Canada, Belgium, Peru, United Kingdom, Egypt, New Zealand, Slovenia, South Africa, Sweden, Hungary, India, Germany, Brazil
-
AstraZenecaCompleted
-
AstraZenecaCompletedBreast CancerUnited States, Brazil, United Kingdom, Germany, Austria, India
-
Hoffmann-La RocheCompletedBreast CancerSpain, Russian Federation, Austria, Italy, Germany, Portugal
-
Queen Mary University of LondonCompletedBreast CancerIreland, United Kingdom, Switzerland, Australia, Belgium, Chile, Denmark, Finland, Germany, Hungary, Italy, Malta, Portugal, Turkey
-
Genentech, Inc.CompletedBreast CancerBelgium, Israel, United States, Spain, Denmark, Germany, Hong Kong, Russian Federation, Australia, New Zealand, Korea, Republic of, Malaysia, Singapore, Italy, Czech Republic, France, Peru, Canada, United Kingdom, Chile, Thailand, Argentin... and more
-
Boston Scientific CorporationBiocompatibles UK LtdCompletedMetastatic Colorectal CancerUnited Kingdom, Austria, France
-
Eli Lilly and CompanyCompletedPancreatic Neoplasms | Metastases, NeoplasmUnited States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
-
University College London HospitalsCompletedBreast Cancer | Hereditary Breast/Ovarian Cancer (brca1, brca2) | brca1 Mutation Carrier | brca2 Mutation CarrierAustralia, Israel, United Kingdom, Spain, Sweden, Portugal